Antiplaque/antigingivitis FDA combination policy endorsed by plaque group.
This article was originally published in The Rose Sheet
Executive Summary
ANTIPLAQUE/ANTIGINGIVITIS COMBINATION POLICY ENDORSED by FDA's Dental Plaque Subcommittee at its meeting May 29 in Gaithersburg, Md. The sub-committee concluded that anticaries and tooth desensitizing agents could be combined appropriately with an approved antiplaque/antigingivitis ingredient or ingredient combination.
You may also be interested in...
W-L Listerine Anticaries Fluoride Rinse Altered Formula Proposed To FDA
Warner-Lambert has changed its proposed fluoride-containing oral anticaries/antiplaque/antigingivitis rinse to a .02% sodium fluoride formula to reflect results from recently conducted market research, W-L says in comments submitted to FDA May 15.
OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program